Skip to main content

Shah Sujal's Form 4 filing

CymaBay Therapeutics, Inc. (CBAY) · filed Nov 14, 2023

Accession no.
0001062993-23-020835
Filed
Nov 14, 2023
Trade date
Nov 13, 2023
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.03M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Shah SujalCIK 0001588861Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 13, 2023Common StockMOption exerciseAcquired+44,008$5.00+$220,040215,309Direct
Nov 13, 2023Common StockSSaleDisposed−44,008$15.89−$699,287.12171,301Direct
Nov 13, 2023Common StockMOption exerciseAcquired+20,855$5.00+$104,275192,156Direct
Nov 13, 2023Common StockSSaleDisposed−20,855$15.89−$331,385.95171,301Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 13, 2023Common StockMOption exerciseDisposed−31,036$0.00$031,036Direct
Nov 13, 2023Common StockMOption exerciseDisposed−12,972$0.00$012,973Direct
Nov 13, 2023Common StockMOption exerciseDisposed−20,855$0.00$020,856Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)